# Evaluating the Safety and Efficacy of Autologous Adipose Tissue-derived Mesenchymal Stem Cell Transplantation on Proinflammatory Cytokines and Anti-inflammatory Cytokines on Ageing-related Low-grade Inflammation Patients.

> **NCT05827757** · PHASE1,PHASE2 · UNKNOWN · sponsor: **DNA International Hospital** · enrollment: 72 (estimated)

## Conditions studied

- Aging Problems
- Aging
- Chronic Inflammation

## Interventions

- **BIOLOGICAL:** autologous adipose-derived mesenchymal stem cell transplantation

## Key facts

- **NCT ID:** NCT05827757
- **Lead sponsor:** DNA International Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-28
- **Primary completion:** 2025-04-13
- **Final completion:** 2025-04-13
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2023-10-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05827757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05827757, "Evaluating the Safety and Efficacy of Autologous Adipose Tissue-derived Mesenchymal Stem Cell Transplantation on Proinflammatory Cytokines and Anti-inflammatory Cytokines on Ageing-related Low-grade Inflammation Patients.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05827757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*